Company profile
CareDx, Inc
NASDAQ: CDNA · Healthcare · Medical - Diagnostics & Research
#232 of 1,422 Healthcare companies by revenue60th-percentile growth
EA Score
78B+FH 77DQ 87GM 61SS 76
v0.1 · 65/100 weight · provisional
↑ filing timeliness, Altman-Z · ↓ 3-yr revenue growth, listing tenure
Methodology →Revenue TTM
$412.8M
Rev growth YoY (TTM)
+19.2%
Net income (FY)
-$21.4M
Employees
765
as of 2026-08-09
Market cap
$2.4B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$379.8M$379.8M2025
Net income-$21.4M-$21.4M2025
Operating income-$30.8M-$30.8M2025
Total assets$413.2M$413.2M2025
Liabilities$110.1M$110.1M2025
Equity$303.1M$303.1M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Service85%
Product15%
By geography
UNITED STATES95%
Non-US5%
The read
What is CareDx, Inc’s revenue?
CareDx, Inc booked $379.8M in FY2025 revenue, growing 14% year over year — faster than most Healthcare companies we track, at a -5.6% net margin.
Peers · Healthcare
Esperion Therapeutics, Inc.61CKrystal Biotech, Inc.77B+Sonida Senior Living, Inc.64CTwist Bioscience Corporation70BArcutis Biotherapeutics, Inc.66BAtea Pharmaceuticals, Inc.47DNeighbors
San Mateo →Key facts
CEOJohn Walter Hanna Jr.
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersSouth San Francisco, CA
ExchangeNASDAQ: CDNA
Employees765
IPO date2014-07-17
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.